[Treatment of rheumatic diseases with nabumetone. Results of a study using the drug in 18,046 patients].
Lemmel
E M
EM
Stroehmann
I
I
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002074:Butanones / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077430:Nabumetone; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002074:Butanones; D000077430:Nabumetone
Behandlung rheumatischer Erkrankungen mit Nabumeton. Ergebnisse einer Anwendungsbeobachtung an 18,047 Patienten.